Home / Cancer and immune system / Bortezomib
ATC L01XG01 · Antineoplastic Agents
Bortezomib shortage
As of 31 Oct 2026, Bortezomib has a reported shortage in 2 of the 5 countries we track (Italy, Spain), covering 4 products.
Countries2/5
Products4packs or presentations
Short since10 Jul 202516 months ago
Earliest return27 Jul 2027company estimate
No return date3products
Main reasonIncreased demand
Timeline
ItalySpain
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | BORTEZOMIB MEDAC | MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATE MBH | 10 Jul 2025 | not given | Commercial decision or withdrawal Motivi commerciali |
| IT | BORTEZOMIB AUROBINDO | Eugia Pharma (Malta) Limited | 24 Apr 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | BORTEZOMIB DR. REDDY'S | DR. REDDY'S S.R.L. | 31 May 2026 | not given | Increased demand Elevata richiesta: forniture discontinue |
| ES | BORTEZOMIB WAVERLEY 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG, 1 vial | Waverley Pharma Europe Limited | 16 Aug 2026 | 27 Jul 2027 | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.